𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of hereditary non polyposis colon cancer (HNPCC) in South Italy: A prospective investigation

✍ Scribed by G. Riegler; A. Savastano; G. Gagliardi; R. Carratu; P. Borgheresi; A. Piscitelli; G.B. Rossi; M.A. Bianco; F. Montanaro; D. Cattaneo; A. Pezzullo; E. Sessa; P. Di Giorgio; V. Baldi; S. De Stefano; G. De Palma; F. Guardascione; P. Spinelli; F. Selvaggi; P. Pastore; O. Saffiotti; M. Martorano; P. Morella; E. Parente; M.A. Bozzi; R. Iorio


Book ID
118880117
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
143 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The risk of brain tumours in hereditary
✍ H. F. A. Vasen; E. A. C. M. Sanders; B. G. Taal; F. M. Nagengast; G. Griffioen; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 417 KB πŸ‘ 2 views

Hereditary non-polyposis colorectal cancer (HNPCC) is known to be associated with several extracolonic cancers, e.g., cancers of the endometrium, stomach, urinary tract, small bowel and ovary. An association between HNPCC and brain tumours has also been reported, although previous risk analysis did

Psychological consequences of predictive
✍ Katja Aktan-Collan; Ari Haukkala; Jukka-Pekka Mecklin; Antti Uutela; Helena KÀÀr πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 61 KB πŸ‘ 1 views

Predictive genetic testing for cancer allows identification of those with the mutation (mutation positive) who should undergo cancer surveillance aiming at early detection of cancer and those without the mutation (mutation negative), whose unnecessary worry can be alleviated and who need not undergo

Life-time risk of different cancers in h
✍ Markku Aarnio; Jukka-Pekka Mecklin; Lauri A. Aaltonen; Minna NystrΓΆm-Lahti; Heik πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 431 KB πŸ‘ 1 views

Identification of hereditary non-polyporis colorectal cancer (HNPCC) indicates theoretical life-time risks of 50% for the descendants of an affected family member and of 100% for the true gene carriers. However, besides colorectal cancer (CRC), many other cancer types and sites are also involved, wh